Evaluation of patients diagnosed with thromboembolism in the emergency department before and during the Covid-19 pandemic

Main Article Content

Mustafa Alpaslan Necmi Baykan Mehmet Oktay Ömer Salt Serhat Koyuncu Oğuzhan Bol Mükerrem Altuntaş

Abstract

Background: A new coronavirus known as severe acute respiratory syndrome coronavirus 2 spread rapidly in late 2019 and caused a worldwide pandemic. Due to the pandemic, people are hesitant to go to the hospital and they move much less compared to normal life, which has caused new health problems to emerge.


Aims: This study aimed to examine the demographic characteristics of patients who admitted to the emergency department due to thromboembolic events before and during the COVID-19 pandemic in our country, and to investigate the effect of the pandemic on thromboembolic events. As a result, it was aimed to determine the effects of the COVID-19 pandemic on thromboembolic events and hospital admissions.


Methods: Patients with a thromboembolic event detected between July 01,2019-December 31, 2019 were classified as Group I, and patients with a thromboembolic event detected between July 01,2019- December 31, 2020 were classified as Group II. A total of 859 patients over the age of 18, who had no previous comorbidities, not pregnant, and were hospitalized and treated due to thromboembolic events were included in the study. 447 of these patients were in group I and 412 were in group II. Only 20 (4.9%) of the patients in Group II had a history of previous Covid 19 infection.


Results: It was observed that there was no significant difference in the comparison of the number of cases of thromboembolic events seen in Group I and Group II (p = 0.536). When looking at the distribution of diseases by month, a significant difference was detected in 2019 (mostly in October)(p=0.006,Chi Square: 59.844), while there was no significant difference in Group II (p=0.503,Chi square:34.263).


Conclusion: From the period after the beginning of the pandemic, we saw that the rate of hospitalization due to thromboembolic event was 4% less than in the same period of the previous year. We think that this may be due to fewer hospital admissions due to the risk of disease transmission during the pandemic period, or the fact that Covid 19 infection does not significantly increase the susceptibility to thrombosis.

Keywords: Covid-19, emergency medicine, pandemic, thromboembolism

Article Details

How to Cite
ALPASLAN, Mustafa et al. Evaluation of patients diagnosed with thromboembolism in the emergency department before and during the Covid-19 pandemic. Medical Research Archives, [S.l.], v. 12, n. 10, oct. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5855>. Date accessed: 22 dec. 2024. doi: https://doi.org/10.18103/mra.v12i10.5855.
Section
Research Articles

References

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;15;395(10223):497-506.

2. WHO (2020). World Health Organization (WHO). Rolling updates on coronavirus disease (COVID-19), https://www.who.int/emergencies/diseases/novelcoronavirus-2019/eventsas-they-happen) . Access date: January 03, 2024.

3. Altınbilek E, Oztürk D, Atasoy C, Ozlem M, Yılmaz F, Kavalcı C. Analysis of the patients who admitted to a Turkish emergency department during covid-19 pandemic. Acta Biomed. 2020; 91(4):e2020201.

4. Mestre-Gómez B, Lorente-Ramos RM, Rogado J, et al. Infanta Leonor Thrombosis Research Group. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2021;51(1):40-6.

5. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738-42.

6. Sagris D, Papanikolaou A, Kvernland A, et al. COVID-19 and ischemic stroke. Eur J Neurol. 2021;28(11):3826-36.

7. Katsoularis I, Fonseca-Rodríguez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;14;398(10300):599-607.

8. Li Y, Man Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke & Vascular Neurology. 2020;5:e000431.

9. Benussi A, Pilotto A, Premi E, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95:910–20.

10. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91:889-91.

11. Rivera-Izquierdo M, Láinez-Ramos-Bossini AJ, de Alba IG, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;23;20(1): 92.

12. Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76(10):970-9.

13. Morelli N, Rota E, Terracciano C, et al. The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 Era. Eur Neurol. 2020;83(2):213-5.

14. Aguiar de Sousa D, Sandset EC, Elkind MSV. The curious case of the missing strokes during the COVID-19 pandemic. Stroke. 2020;51(7):1921-3.

15. Arai R, Fukamachi D, Ebuchi Y, et al. Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center. Heart Vessels. 2021;36(10):1474-83.

16. Choi H, Lee JH, Park HK, et al. Impact of the COVID-19 pandemic on patient delay and clinical outcomes for patients with acute myocardial infarction. J Korean Med Sci. 2022;30;e167.

17. Gąsecka A, Borovac JA, Guerreiro RA, et al. Thrombotic complications in patients with covid-19: pathophysiological mechanisms, diagnosis, and treatment. Cardiovasc Drugs Ther. 2021;35 (2):215-29.

18. Mohammad MA, Koul S, Olivecrona GK, et al. Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. Heart. 2020;106(23) :1812-8.

19. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.

20. Lodigiani C, Iapichino G, Carenzo L, et al; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14.

21. Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–50.

22. Helms J, Tacquard C, Severac F, et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089–98.

23. Shahjouei S, Naderi S, Li J, et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study. EBioMedicine. 2020;59:102939.

24. Qureshi AI, Baskett WI, Huang W, et al. Acute ischemic stroke and COVID-19: an analysis of 27 676 Patients. Stroke. 2021;52(3):905-12.

25. Qin C, Zhou L, Hu Z, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51:2219–3.

26. Morassi M, Bagatto D, Cobelli M, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020;267:2185–92.

27. Porfidia A, Valeriani E, Pola R. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res. 2020;196:67-74.

28. Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol. 2020;42(1):19-20.

29. Poissy J, Goutay J, Caplan M, et al. Lille ICU Haemostasis COVID-19 group. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;14:184-6.

30. Cantador E, Núñez A, Sobrino P, et al. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients. J Thromb Thrombolysis. 2020;50(3):543-7.

31. Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864-72.